Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/14/14 → 12/31/20 |
Funding
- PPD Development (Prot #PCYC-1127-CA // Prot #PCYC-1127-CA)
- Pharmacyclics, Inc. (Prot #PCYC-1127-CA // Prot #PCYC-1127-CA)
Prot #PCYC-1127-CA: A Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study of Ibrutinib or Placebo in Combination With Rituximab in Subjects with Previously Treated Waldenstrom’s Macroglobulinemia
- Ma, Shuo (PD/PI)
Project: Research project